• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

世界卫生组织土耳其慢性呼吸道疾病全球防治联盟(GARD土耳其)

The WHO global alliance against chronic respiratory diseases in Turkey (GARD Turkey).

作者信息

Yorgancioğlu A, Türktaş H, Kalayci O, Yardim N, Buzgan T, Kocabaş A, Karlikaya C, Yildiz F, Ergün P, Mungan D, Kart L, Göktaş E, Musaonbaşioğlu S, Gündoğan A, Akdağ R, Akçay S, Akin M, Akkurt I, Altan P, Altunsu T, Arpaci N, Aydin C, Aydin S, Aydinli F, Aytaç B, Bavbek S, Biber C, Bingöl Karakoç G, Ceyhun G, Cakir B, Celik G, Cetinkaya T, Ciçek M E, Coban S C, Cobanoğlu N, Com S, Cöplü L, Demirkazik A, Doğan E, Ekmekçi E B, Elbir M, Erdoğan A, Ergüder T, Gemicioğlu B, Gögen S, Gülbahar O, Güngör H, Horzum E, Içer Y, Imamecioğlu A R, Kahraman N, Kakillioğlu T, Kalyoncu F, Karakaya M, Karakaya G, Karaodul G, Kesici C, Keskinkiliç B, Kilinç O, Kirmizitaş F, Kosdak M, Köktürk N, Metintaş M, Numanoğlu S C, Gümrükçüoğlu O F, Onal Z, Onal B, Ozacar R, Ozen H A, Ozkan S, Oztürk F, Polat H, Saçkesen C, Selçuk T, Serin G, Sönmez G, Sahin M, Sahinöz S, Sahinöz T, Simşek B, Tartan N, Toprak A, Tugay T, Tuncer A, Uçan E S, Unüvar N, Yapicikardeşler B, Yildirim N, Yol S, Yüksel H, Khaltaev N, Cruz A, Minelli E, Bateman E, Baena Cagnani C, Dahl R, Bousquet J

机构信息

Turkish Thoracic Society, Turkey.

出版信息

Tuberk Toraks. 2009;57(4):439-52.

PMID:20037863
Abstract

In order to prevent and control non-communicable diseases (NCDs), the 61st World Health Assembly has endorsed an NCD action plan (WHA resolution 61.14). A package for essential NCDs including chronic respiratory diseases (CRDs) has also been developed. The Global Alliance against Chronic Respiratory Diseases (GARD) is a new but rapidly developing voluntary alliance that is assisting World Health Organization (WHO) in the task of addressing NCDs at country level. The GARD approach was initiated in 2006. GARD Turkey is the first comprehensive programme developed by a government with all stakeholders of the country. This paper provides a summary of indicators of the prevalence and severity of chronic respiratory diseases in Turkey and the formation of GARD Turkey.

摘要

为预防和控制非传染性疾病(NCDs),第61届世界卫生大会批准了一项非传染性疾病行动计划(世界卫生大会第61.14号决议)。还制定了一套包括慢性呼吸道疾病(CRDs)在内的基本非传染性疾病一揽子计划。全球抗击慢性呼吸道疾病联盟(GARD)是一个新成立但发展迅速的自愿联盟,正在协助世界卫生组织(WHO)在国家层面开展应对非传染性疾病的工作。GARD方法于2006年启动。GARD土耳其是由该国政府与所有利益相关者共同制定的首个综合项目。本文概述了土耳其慢性呼吸道疾病的患病率和严重程度指标以及GARD土耳其的形成情况。

相似文献

1
The WHO global alliance against chronic respiratory diseases in Turkey (GARD Turkey).世界卫生组织土耳其慢性呼吸道疾病全球防治联盟(GARD土耳其)
Tuberk Toraks. 2009;57(4):439-52.
2
Integration of GARD Turkey national program with other non-communicable diseases plans in Turkey.将土耳其痛风与罕见病防治计划(GARD Turkey)国家项目与土耳其其他非传染性疾病计划相结合。
Tuberk Toraks. 2010;58(2):213-28.
3
Global Alliance against Chronic Respiratory Diseases.全球抗击慢性呼吸道疾病联盟
Eur Respir J. 2007 Feb;29(2):233-9. doi: 10.1183/09031936.00138606.
4
Global alliance against chronic respiratory diseases.全球抗击慢性呼吸道疾病联盟
Allergy. 2007 Mar;62(3):216-23. doi: 10.1111/j.1398-9995.2007.01307.x.
5
[Romanian Society of Pneumology included in GARD (Global Alliance Against Chronic Respiratory Diseases)].[罗马尼亚肺病学会被纳入全球抗击慢性呼吸道疾病联盟(GARD)]
Pneumologia. 2008 Oct-Dec;57(4):257-8.
6
[Global alliance against chronic respiratory diseases].全球抗击慢性呼吸道疾病联盟
Pneumonol Alergol Pol. 2008;76(3):160-9.
7
[GARD (Global Alliance against chronic Respiratory Diseases)].[全球抗击慢性呼吸疾病联盟(GARD)]
Rev Mal Respir. 2006 Sep;23(4 Pt 2):10S73-10S75.
8
Global alliance against chronic respiratory diseases in Italy (GARD-Italy): strategy and activities.意大利全球防治慢性呼吸系统疾病联盟(GARD-Italy):策略与活动。
Respir Med. 2012 Jan;106(1):1-8. doi: 10.1016/j.rmed.2011.10.002. Epub 2011 Oct 22.
9
[Global Alliance Against Chronic Respiratory Diseases (GARD)].全球抗击慢性呼吸道疾病联盟(GARD)
Pneumonol Alergol Pol. 2008;76(3):127.
10
The National Action Plan for the Prevention and Control of Non-communicable Diseases and Health Promotion in Pakistan--Prelude and finale.巴基斯坦非传染性疾病预防控制与健康促进国家行动计划——序幕与终曲
J Pak Med Assoc. 2004 Dec;54(12 Suppl 3):S1-8.

引用本文的文献

1
Global, regional, and national burden of chronic respiratory diseases,1990-2021 and predictions to 2035: analysis of data from the global burden of disease study 2021.1990年至2021年全球、区域和国家慢性呼吸道疾病负担及到2035年的预测:全球疾病负担研究2021数据分析
Ann Med. 2025 Dec;57(1):2530225. doi: 10.1080/07853890.2025.2530225. Epub 2025 Jul 8.
2
Health-Promoting Behaviors, Health Literacy, and Levels of Knowledge about Smoking-Related Diseases among Smokers and Non-smokers: A Cross-Sectional Study.吸烟者和非吸烟者的健康促进行为、健康素养及吸烟相关疾病知识水平:一项横断面研究
Tuberc Respir Dis (Seoul). 2021 Apr;84(2):140-147. doi: 10.4046/trd.2020.0158. Epub 2021 Jan 26.
3
Diagnostic Value of Galactomannan in Bronchoalveolar Lavage Fluid for Chronic Respiratory Disease with Pulmonary Aspergillosis.
支气管肺泡灌洗液半乳甘露聚糖检测对慢性肺部曲霉菌病的诊断价值
J Clin Microbiol. 2020 Feb 24;58(3). doi: 10.1128/JCM.01308-19.
4
Incorporating the Environmental Impact into a Budget Impact Analysis: The Example of Adopting RESPIMAT Re-usable Inhaler.将环境影响纳入预算影响分析:采用 RESPIMAT 可重复使用吸入器的示例。
Appl Health Econ Health Policy. 2020 Jun;18(3):433-442. doi: 10.1007/s40258-019-00540-0.
5
A Budget Impact Model to Estimate the Environmental Impact of Adopting RESPIMAT Re-usable in the Nordics and Benelux.采用 RESPIMAT 可重复使用系统估算北欧和比荷卢地区采用该系统的环境影响的预算影响模型。
Adv Ther. 2019 Dec;36(12):3435-3445. doi: 10.1007/s12325-019-01114-1. Epub 2019 Oct 17.
6
The Reference Site Collaborative Network of the European Innovation Partnership on Active and Healthy Ageing.欧洲积极和健康老龄化创新伙伴关系参考站点协作网络
Transl Med UniSa. 2019 Jan 6;19:66-81. eCollection 2019 Jan-Jun.
7
Country activities of Global Alliance against Chronic Respiratory Diseases (GARD): focus presentations at the 11th GARD General Meeting, Brussels.全球抗击慢性呼吸疾病联盟(GARD)的国家活动:在布鲁塞尔举行的第11届GARD大会上的重点报告
J Thorac Dis. 2018 Dec;10(12):7064-7072. doi: 10.21037/jtd.2018.12.84.
8
A strategy for measuring health outcomes and evaluating impacts of interventions on asthma and COPD-common chronic respiratory diseases in Global Alliance against Chronic Respiratory Diseases (GARD) countries.一种针对全球抗击慢性呼吸道疾病联盟(GARD)国家中哮喘和慢性阻塞性肺疾病(COPD)这两种常见慢性呼吸道疾病的健康结果测量及干预措施影响评估策略。
J Thorac Dis. 2018 Aug;10(8):5170-5177. doi: 10.21037/jtd.2018.08.100.
9
Adherence to COPD treatment in Turkey and Saudi Arabia: results of the ADCARE study.土耳其和沙特阿拉伯慢性阻塞性肺疾病(COPD)治疗的依从性:ADCARE研究结果
Int J Chron Obstruct Pulmon Dis. 2018 Apr 27;13:1377-1388. doi: 10.2147/COPD.S150411. eCollection 2018.
10
Asthma in the context of global alliance against respiratory diseases (GARD) in Turkey.土耳其全球抗击呼吸道疾病联盟(GARD)背景下的哮喘
J Thorac Dis. 2018 Mar;10(3):2052-2058. doi: 10.21037/jtd.2018.03.39.